FDA Grants Approval for Dr. Reddy's Loratadine and Pseudoephedrine Sulfate
The FDA has granted approval for Dr. Reddy's ANDA220448 for Loratadine and Pseudoephedrine Sulfate, with a standard review priority.
Therapeutic Area
Therapeutic area intelligence for Antihistamine and Decongestant with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No related entities indexed yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.